MESABI TRUST (MSB) Financials, Dividends & Stock Info
Explore comprehensive financial data for MESABI TRUST, provided completely free. Analyze revenue, net income, profit margins, dividend history, and key financial ratios to make informed investment decisions.
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
MESABI TRUST (MSB) is a company.
MESABI TRUST Financial Health ScoreFY2025
Moderate health; several metrics need attention
-39 pts YoYThis Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Data Highlights
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
5-Year Revenue & Net Income Trend
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
About MESABI TRUST
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Profitability Data Under ReviewProfitability metrics are being verified. Some SEC filing data may require additional validation.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Balance Sheet Data LimitedInsufficient data to assess financial health.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
MESABI TRUST 10-Year Revenue, Profit & Cash Flow History
Revenue has grown at a 0.4% CAGR over the past 10 years.
Annual Financials
FY2025 - FY2015| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.9M(-68.0%) | $71.5M(+175.4%) | $26.0M(-18.9%) | $32.0M(-32.4%) | $47.3M(+37.1%) | $34.5M(+216.8%) | $10.9M(+12.0%) | $9.7M(-62.7%) | $26.1M(+18.3%) | $22.0M(-30.2%) |
| Net Income | $19.0M(-72.4%) | $68.8M(+193.8%) | $23.4M(-22.1%) | $30.1M(-34.0%) | $45.6M(+36.3%) | $33.4M(+242.3%) | $9.8M(+14.1%) | $8.6M(-65.4%) | $24.8M(+17.6%) | $21.1M(-31.3%) |
| Total Assets | $101.7M | $26.7M | $14.1M | $53.9M | $22.9M | $23.6M | $35.5M | $26.1M | $14.2M | $9.8M |
| Total Debt | - | - | - | - | - | - | - | - | - | - |
| Total Equity | $21.0M | $11.4M | $30.8M | $16.5M | $11.8M | $16.8M | - | - | - | - |
| Profit Margin | 83.0% | 96.2% | 90.2% | 94.0% | 96.3% | 96.9% | 89.7% | 88.0% | 95.0% | 95.5% |
| ROE | 90.5% | 601.2% | 76.0% | 182.4% | 385.1% | 198.9% | - | - | - | - |
| ROA | 18.7% | 257.6% | 165.8% | 55.8% | 198.7% | 141.3% | 27.5% | 32.8% | 173.8% | 214.5% |
Quarterly Financials
Last 8 quarters| Metric | Q1 2027 | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.7M | $91.7M | $12.7M | $6.3M | $16.6M | $11.7M | $1.8M | $9.9M |
| Net Income | $3.6M | $87.2M | $8.9M | $3.5M | $14.3M | $10.2M | $1.0M | $8.3M |
| Total Assets | $24.4M | $101.7M | $101.7M | $101.7M | $26.7M | $26.7M | $26.7M | $14.1M |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Insider Trading
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
MESABI TRUST Free Cash Flow & Dividend Coverage
Cash Flow History
FY2015 - FY2025| Metric | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | $21.3M | $24.3M | $8.2M | $12.6M | $29.5M | $45.5M | $34.6M | $20.8M | $62.8M | $14.6M |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
| FCF Margin | - | - | - | - | - | - | - | - | - | - |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
MESABI TRUST Risk Factors
Company-disclosed SEC risk factors
Risk factors are disclosed by the company in its SEC Form 10-K, Item 1A. Billiver does not classify or summarize company-specific legal, operational, financial, or market risks here.
Source note: the SEC Form 10-K includes Item 1A, "Risk Factors." The full risk-factor text should be read from the company’s own SEC filing.
MESABI TRUST FAQ
Does MESABI TRUST pay dividends?
No, MESABI TRUST (MSB) does not currently pay dividends to shareholders.
What is MESABI TRUST's financial health score?
MESABI TRUST has a financial health score of 61/100 (Grade: C), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of MESABI TRUST financial data are available?
10 years of financial data are available for MESABI TRUST from FY2015 to FY2025. All figures are compiled from SEC EDGAR 10-K filings.